Mechanism-based bioanalysis and biomarkers for hepatic chemical stress

References

• Adachi N, Hirota M, Hamaguchi M, Okamoto K, Watanabe K, Endo F. (2004). Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 342:127–36.
   PubMed Web of Science ®Google Scholar
• Ashamiss F, Wierzbicki Z, Chrzanowska A, Scibior D, Pacholczyk M, Kosieradzki M, Lagiewska B, Porembska Z, Rowinski W. (2004). Clinical significance of arginase after liver transplantation. Ann Transplant 9:58–60.
   PubMedGoogle Scholar
• Ashrafian H, Horowitz JD, Frenneaux MP. (2007). Perhexiline. Cardiovasc Drug Rev 25:76–97.
   PubMed Web of Science ®Google Scholar
• Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. (2004). Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury [see comment]. Hepatology 40:1078–87.
   PubMed Web of Science ®Google Scholar
• Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, Pappo O, Sulkes J, Neuman MG, Kaganovsky E, Kfir B, Tur-Kaspa R, Klein T. (2003). Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J Intern Med 254:168–75.
   PubMed Web of Science ®Google Scholar
• Berson A, De Beco V, Letteron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D. (1998). Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764–74.
   PubMed Web of Science ®Google Scholar
• Boelsterli UA, Lim PLK. (2007). Mitochondrial abnormalities — a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol 220:92–107.
   PubMed Web of Science ®Google Scholar
• Bonafe L, Troxler H, Kuster T, Heizmann CW, Chamoles NA, Burlina AB, Blau N. (2000). Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias. Mol Genet Metab 69:302–11.
   PubMed Web of Science ®Google Scholar
• Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. (2003). Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551–60.
   PubMed Web of Science ®Google Scholar
• Bondy GS, Armstrong CL, Curran IHA, Barker MG, Mehta R. (2000). Retrospective evaluation of serum ornithine carbamyltransferase activity as an index of hepatotoxicity in toxicological studies with rats. Toxicol Lett 114:163–71.
   PubMed Web of Science ®Google Scholar
• Bota DA, Davies KJA. (2002). Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 4:674–80.
   PubMed Web of Science ®Google Scholar
• Brinkman K, ter Hofstede HJM, Burger DM, Smeitinkt JAM, Koopmans PP. (1998). Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. Aids 12:1735–44.
   PubMed Web of Science ®Google Scholar
• Carakostas MC, Gossett KA, Church GE, Cleghorn BL. (1986). Evaluating toxin-induced hepatic-injury in rats by laboratory results and discriminant analysis. Vet athol 23:264–9.
   PubMed Web of Science ®Google Scholar
• Carthew RW, Sontheimer EJ. (2009). Origins and mechanisms of miRNAs and siRNAs. Cell 136:642–55.
   PubMed Web of Science ®Google Scholar
• Caulin C, Salvesen GS, Oshima RG. (1997). Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138:1379–94.
   PubMed Web of Science ®Google Scholar
• Cui LX, Yoon SY, Schinazi RF, Sommadossi JP. (1995). Cellular and molecule events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-lodouracil in human liver cells. J Clin Investig 95:555–63.
   PubMed Web of Science ®Google Scholar
• Cummings J, Hodgkinson C, Odedra R, Sini P, Heaton SP, Mundt KE, Ward TH, Wilkinson RW, Growcott J, Hughes A, Dive C. (2008a). Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity. Mol Cancer Therapeut 7:455–63.
   PubMed Web of Science ®Google Scholar
• Cummings J, Ranson M, Lacasse E, Ganganagari JR, St-Jean M, Jayson G, Durkin J, Dive C. (2006). Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer 95:42–8.
   PubMed Web of Science ®Google Scholar
• Cummings J, Ward TH, Greystoke A, Ranson M, Dive C. (2008b). Biomarker method validation in anticancer drug development. Br J Pharmacol 153:646–56.
   PubMed Web of Science ®Google Scholar
• Dieckhaus CM, Miller TA, Sofia RD, Macdonald TL. (2000). A mechanistic approach to understanding species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions. Drug Metab Disposit 28:814–22.
   PubMed Web of Science ®Google Scholar
• Divincenzo GD, Krasavage WJ. (1974). Serum ornithine carbamyl transferase as a liver response test for exposure to organic solvents. Am Ind Hyg Assoc J 35:21–9.
   PubMed Web of Science ®Google Scholar
• Dykens JA, Jamieson JD, Marroquin LD, Nadanaciva S, Xu JHJ, Dunn MC, Smith AR, Will Y. (2008). In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicol Sci 103:335–45.
   PubMed Web of Science ®Google Scholar
• Foster GR, Goldin RD, Oliveira DB. (1989). Serum F protein: a new sensitive and specific test of hepatocellular damage. Clin Chim Acta 184:85–92.
   PubMed Web of Science ®Google Scholar
• Gibson G, Skett, P. (2001). Introduction to drug metabolism. Nelson Thornes; Cheltenham, UK.
   Google Scholar
• Goto S, Seo T, Hagiwara T, Ueda K, Yamauchi T, Nagata S, Ando Y, Ishitsu T, Nakagawa K. (2008). Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients. J Pharm Pharmacol 60:267–72.
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. (1998). Mitochondria and apoptosis. Science 281 (5381):1309–12.
   PubMed Web of Science ®Google Scholar
• Gregersen N. (1985). The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Scand J Clin Lab Invest Suppl 174:1–60.
   PubMedGoogle Scholar
• Gregus Z, Madhu C, Klaassen CD. (1988). Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. J Pharmacol Exp Therapeut 244:91–9.
   PubMed Web of Science ®Google Scholar
• Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270 (43):25752–61.
   PubMed Web of Science ®Google Scholar
• Hu YM, Benedict MA, Ding LY, Nunez G. (1999). Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J 18:3586–95.
   PubMed Web of Science ®Google Scholar
• Hunzinger C, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Zengerling H, Schoepf R, Groebe K, Cahill MA, Osiewacz HD, et al. (2006). Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms including N-formylkynurenine modifications as part of a protein biomarker signature for reactive oxidative species. J Proteome Res. 5:625–33.
   PubMed Web of Science ®Google Scholar
• Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N. (2006). Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 36:1028–38.
   PubMed Web of Science ®Google Scholar
• Jaeschke H. (2006). How relevant are neutrophils for acetaminophen hepatotoxicity? [comment]. Hepatology 43:1191–4.
   PubMed Web of Science ®Google Scholar
• Khayrollah AA, Al-Tamer YY, Taka M, Skursky L. (1982). Serum alcohol dehydrogenase activity in liver diseases. Ann Clin Biochem 19 (Pt 1):35–42.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Mori M, Naruto T, Kobayashi N, Sugai T, Imagawa T, Yokota S. (2004). Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury. Pediatr Int 46:685–92.
   PubMed Web of Science ®Google Scholar
• Kola I, Landis J. (2004). Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711–15.
   PubMed Web of Science ®Google Scholar
• Kono H, Rock KL. (2008). How dying cells alert the immune system to danger. Nat Rev Immunol 8:279–89.
   PubMed Web of Science ®Google Scholar
• Ku NO, Omary MB. (2001). Effect of mutation and phosphorylation of type I keratins on their caspase-mediated degradation. J Biol Chem 276 (29):26792–8.
   PubMed Web of Science ®Google Scholar
• Labbe G, Pessayre D, Fromenty B. (2008). Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fund Clin Pharmacol 22:335–53.
   PubMed Web of Science ®Google Scholar
• Lazarou J, Pomeranz BH, Corey PN. (1998). Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J Am Med Assoc 279:1200–5.
   PubMed Web of Science ®Google Scholar
• Lee YH, Chung MCM, Lin QS, Boelsterli UA. (2008). Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/–) mice: Two-stage oxidative injury. Toxicol Appl Pharmacol 231:43–51.
   PubMed Web of Science ®Google Scholar
• Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, et al. (1998). The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta Bioenerget 1366:177–96.
   PubMed Web of Science ®Google Scholar
• Lewis W, Levine ES, Griniuviene B, Tankersley KO, Colacino JM, Sommadossi JP, Watanabe KA, Perrino FW. (1996). Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci USA 93:3592–7.
   PubMed Web of Science ®Google Scholar
• Lindblom P, Rafter I, Copley C, Andersson U, Hedberg JJ, Berg AL, Samuelsson A, Hellmold H, Cotgreave I, Glinghammar B. (2007). Isoforms of alanine aminotransferases in human tissues and serum — differential tissue expression using novel antibodies. Archiv Biochem Biophys 466:66–77.
   PubMed Web of Science ®Google Scholar
• Liu ZX, Govindarajan S, Kaplowitz N. (2004). Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127:1760–74.
   PubMed Web of Science ®Google Scholar
• Liu ZX, Han D, Gunawan B, Kaplowitz N. (2006). Neutrophil depletion protects against murine acetaminophen hepatotoxicity. [see comment]. Hepatology 43:1220–30.
   PubMed Web of Science ®Google Scholar
• Lucena MI, Carvajal A, Andrade RJ, Velasco A. (2003). Antidepressant-induced hepatotoxicity. Expert Opin Drug Saf 2:249–62.
   PubMedGoogle Scholar
• Masson MJ, Carpenter LD, Graf ML, Pohl LR. (2008). Pathogenic Role of NKT and NK cells in acetaminophen-induced liver injury is dependent on the presence of DMSO. Hepatology 48:889–97.
   PubMed Web of Science ®Google Scholar
• McKenzie R, Fried MW, Sallie R, Conjeevaram H, Dibisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, et al. (1995). Hepatic-failure and lactic-acidosis due to fialuridine (FIAU), an investigational nucleoside analog for chronic hepatitis-B. N Engl J Med 333 (17):1099–105.
   PubMed Web of Science ®Google Scholar
• Meneses-Lorente G, Guest PC, Lawrence J, Muniappa N, Knowles MR, Skynner HA, Salim K, Cristea I, Mortishire-Smith R, Gaskell SJ, et al. (2004). A proteomic investigation of drug-induced steatosis in rat liver. Chem Res Toxicol 17:605–12.
   PubMed Web of Science ®Google Scholar
• Miller TJ, Knapton A, Adeyemo O, Noory L, Weaver J, Hanig JP. (2008). Cytochrome c: a non-invasive biomarker of drug-induced liver injury. J Appl Toxicol 28:815–28.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. [see comment]. Proc Natl Acad Sci USA 105 (30):10513–18.
   PubMed Web of Science ®Google Scholar
• Murayama H, Igarashi M, Mori M, Fukuda Y, Ikemoto M, Nagata A. (2006). A sensitive ELISA for serum omithine carbamoyltransferase utilizing the enhancement of immunoreactivity at alkaline pH. Clin Chim Acta 368:125–30.
   PubMed Web of Science ®Google Scholar
• Murayama H, Ikemoto M, Fukuda Y, Nagata A. (2008). Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats. Clin Chim Acta 391:31–5.
   PubMed Web of Science ®Google Scholar
• Murayama H, Ikemoto M, Hamaoki M. (2009a). Ornithine carbamyltransferase is a sensitive marker for alcohol-induced liver injury. Clin Chim Acta 401:100–4.
   PubMed Web of Science ®Google Scholar
• Murayama H, Ikemoto M, Nagata A. (2009b). Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 24:270–7.
   PubMed Web of Science ®Google Scholar
• Nadanaciva S, Bernal A, Aggeler R, Capaldi R, Will Y. (2007). Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol In Vitro 21:902–11.
   PubMed Web of Science ®Google Scholar
• Navarro VJ, Senior JR. (2006). Drug-related hepatotoxicity. [see comment]. N Engl J Med 354:731–9.
   PubMed Web of Science ®Google Scholar
• Nishida N, Sugimoto T, Araki A, Woo M, Sakane Y, Kobayashi Y. (1987). Carnitine metabolism in valproate-treated rats — the effect of L-carnitine supplementation. Pediatr Res 22:500–3.
   PubMed Web of Science ®Google Scholar
• Nulton-Persson AC, Szweda LI. (2001). Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 276 (26):23357–61.
   PubMed Web of Science ®Google Scholar
• Nunez M, Soriano V. (2005). Hepatotoxicity of antiretrovirals — incidence, mechanisms and management. Drug Saf 28:53–66.
   PubMed Web of Science ®Google Scholar
• O’Brien PJ, Slaughter MR, Polley SR, Kramer K. (2002). Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab. Anim. 36:313–21.
   Google Scholar
• O’Brien PJ, Slaughter MR, Swain A, Birmingham JM, Greenhill RW, Elcock F, Bugelski PJ. (2000). Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant system. Hum Exp Toxicol 19:277–83.
   PubMed Web of Science ®Google Scholar
• Ohuchi T, Tada K, Akamatsu K. (1995). Endogenous ET-1 contributes to liver injury induced by galactosamine and endotoxin in isolated perfused rat liver. Am J Physiol 268 (6 Pt 1):G997–1003.
   PubMed Web of Science ®Google Scholar
• Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194–205.
   PubMed Web of Science ®Google Scholar
• Pakenham G, Lango J, Buonarati M, Morin D, Buckpitt A. (2002). Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivity of naphthalene epoxidation. Drug Metab Disposit 30:247–53.
   PubMed Web of Science ®Google Scholar
• Park BK, Kitteringham NR. (1990). Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications. Xenobiotica 20:1171–85.
   PubMed Web of Science ®Google Scholar
• Park BK, Kitteringham NR, Maggs JL, Pirmohamed M, Williams DP. (2005). The role of metabolic activation in drug-induced hepatotoxicity. Annu Rev Pharmacol Toxicol 45:177–202.
   PubMed Web of Science ®Google Scholar
• Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. (2004). Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370–7.
   PubMed Web of Science ®Google Scholar
• Pereira CV, Moreira AC, Pereira SP, Machado NG, Carvalho FS, Sardao VA, Oliveira PJ. (2009). Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? Curr Drug Saf 4:34–54.
   PubMedGoogle Scholar
• Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 329 (7456):15–9.
   PubMed Web of Science ®Google Scholar
• Rinaldo P. (2001). Fatty acid transport and mitochondrial oxidation disorders. Semin Liver Dis 21:489–500.
   PubMed Web of Science ®Google Scholar
• Sakaida I, Kimura T, Yamasaki T, Fukumoto Y, Watanabe K, Aoyama M, Okita K. (2005). Cytochrome c is a possible new marker for fulminant hepatitis in humans. J Gastroenterol 40:179–85.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (6894):191–5.
   PubMed Web of Science ®Google Scholar
• Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B. (2007). The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Physiol Cell Physiol 293:C12–21.
   PubMed Web of Science ®Google Scholar
• Schmidt ES, Schmidt FW. (1988). Glutamate-dehydrogenase — biochemical and clinical aspects of an interesting enzyme. Clin Chim Acta 173:43–56.
   PubMed Web of Science ®Google Scholar
• Schutte B, Henfling M, Kolgen W, Bouman M, Meex S, Leers MP, Nap M, Bjorklund V, Bjorklund P, Bjorklund B, et al. (2004). Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res 297:11–26.
   PubMed Web of Science ®Google Scholar
• Sim KG, Carpenter K, Hammond J, Christodoulou J, Wilcken B. (2002a). Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders. Metab Clin Exp 51:366–71.
   PubMed Web of Science ®Google Scholar
• Sim KG, Hammond J, Wilcken B. (2002b). Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta 323:37–58.
   PubMed Web of Science ®Google Scholar
• Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, Kakazu Y, Ishikawa T, Robert M, Nishioka T, et al. (2006). Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281 (24):16768–76.
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, et al. (2003). High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. [see comment]. Arth Rheumat 48:971–81.
   PubMed Web of Science ®Google Scholar
• Tao GZ, Li DH, Zhou Q, Toivola DM, Strnad P, Sandesara N, Cheung RC, Hong A, Omary MB. (2008). Monitoring of epithelial cell caspase activation via detection of durable keratin fragment formation. J Pathol 215:164–74.
   PubMed Web of Science ®Google Scholar
• Tegeris AS, Smalley HE, Earl FL, Curtis JM. (1969). Ornithine carbamyl transferase as a liver function test comparative studies in dog swine and man. Toxicol Appl Pharmacol 14:54–66.
   PubMed Web of Science ®Google Scholar
• Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, et al. (2007). Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. [see comment]. Nature Immunol 8:487–96; erratum 8:780.
   PubMed Web of Science ®Google Scholar
• Wagner S, Scholz K, Sieber M, Kellert M, Voelkel W. (2007). Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine. Analyt Chem 79:2918–26.
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (5425):248–51.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Zhiyuan H, Hood L, Galas D. (2009). Circulating microRNAs, potential biomarkers of drug-induced liver injury. Proc Natl Acad Sci USA. 106(11):4402–7.
   PubMed Web of Science ®Google Scholar
• Wang SF, Zhang LB, Gazmuri RJ, Yang CF. (2008). In-vivo external sensor for mitochondrial injury: circulating cytochrome c. Paper presented at the 3rd IEEE Sensors Applications Symposium; 12–14 February 2008; Atlanta, GA, USA. IEEE. p. 13–15.
   Google Scholar
• Watanabe Y, Mori S, Fujiyama S, Sato T, Mori M. (1994a). Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked-immunosorbent assay in patients with liver diseases. Enz Prot 48:18–26.
   PubMedGoogle Scholar
• Watanabe Y, Mori S, Ozaki M, Fujiyama S, Sato T, Mori M. (1994b). A sensitive enzyme-linked-immunosorbent assay of serum ornithine carbamoyltransferase. Enz Prot 48:10–17.
   PubMedGoogle Scholar
• Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. (2006). In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44:27–33.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. (2006). Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 33:359–63.
   PubMed Web of Science ®Google Scholar
• Zamzami N, Kroemer G. (2001). The mitochondrion in apoptosis: how Pandora’s box opens. Nat Rev Mol Cell Biol 2:67–71.
   PubMed Web of Science ®Google Scholar
• Zieve L, Anderson WR, Dozeman R, Draves K, Lyftogt C. (1985). Acetaminophen liver injury: sequential changes in two biochemical indices of regeneration and their relationship to histologic alterations. J Lab Clin Med 105:619–24.
   PubMed Web of Science ®Google Scholar